DK140003C - - Google Patents

Info

Publication number
DK140003C
DK140003C DK1475A DK1475A DK140003C DK 140003 C DK140003 C DK 140003C DK 1475 A DK1475 A DK 1475A DK 1475 A DK1475 A DK 1475A DK 140003 C DK140003 C DK 140003C
Authority
DK
Denmark
Application number
DK1475A
Other languages
Danish (da)
Other versions
DK140003B (en
DK1475A (en
Inventor
H Bachmayer
G Schmidt
Original Assignee
Sandoz A.G.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz A.G. filed Critical Sandoz A.G.
Publication of DK1475A publication Critical patent/DK1475A/da
Publication of DK140003B publication Critical patent/DK140003B/en
Application granted granted Critical
Publication of DK140003C publication Critical patent/DK140003C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
DK1475AA 1974-01-14 1975-01-06 Method for isolating hemagglutinin and neuraminidase components from an influenza virus. DK140003B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (en) 1974-01-14 1974-01-14

Publications (3)

Publication Number Publication Date
DK1475A DK1475A (en) 1975-09-01
DK140003B DK140003B (en) 1979-06-05
DK140003C true DK140003C (en) 1979-10-29

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
DK1475AA DK140003B (en) 1974-01-14 1975-01-06 Method for isolating hemagglutinin and neuraminidase components from an influenza virus.

Country Status (27)

Country Link
JP (2) JPS58407B2 (en)
AT (1) AT345449B (en)
AU (1) AU500250B2 (en)
BE (1) BE824372A (en)
CA (1) CA1049406A (en)
CH (1) CH589453A5 (en)
CS (1) CS191254B2 (en)
DD (1) DD116239A5 (en)
DE (1) DE2500785B2 (en)
DK (1) DK140003B (en)
ES (1) ES433759A1 (en)
FI (1) FI54053C (en)
FR (1) FR2257305B1 (en)
GB (1) GB1498261A (en)
HK (1) HK56380A (en)
HU (1) HU173920B (en)
IE (1) IE40794B1 (en)
IL (1) IL46426A (en)
MY (1) MY8100204A (en)
NL (1) NL166622C (en)
NO (1) NO143128C (en)
PH (1) PH14458A (en)
PL (1) PL93689B1 (en)
SE (1) SE427238B (en)
SU (1) SU616997A3 (en)
YU (1) YU41289B (en)
ZA (1) ZA75259B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (en) * 1977-07-13 1979-02-01 Sandoz Ag SUBUNIT VACCINE
JPH0688911B2 (en) * 1985-06-06 1994-11-09 国立予防衛生研究所長 Influenza vaccine and method for producing the same
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (en) 1997-11-25 1999-06-02 Duphar International Research B.V Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
DE19938767C2 (en) * 1999-08-16 2002-10-24 Tad Pharma Gmbh subunit vaccines
NZ567817A (en) * 2005-11-01 2012-01-12 Novartis Vaccines & Diagnostic Cell-derived viral vaccines with low levels of residual cell DNA by beta-propiolactone treatment
AU2008293513B2 (en) * 2007-08-28 2013-11-21 Nanotherapeutics, Inc. Method for producing viral vaccines
EP3068791B1 (en) 2013-11-15 2020-07-29 Novartis AG Removal of residual cell culture impurities

Also Published As

Publication number Publication date
SE427238B (en) 1983-03-21
DK140003B (en) 1979-06-05
FR2257305A1 (en) 1975-08-08
YU41289B (en) 1987-02-28
HK56380A (en) 1980-10-16
JPS58407B2 (en) 1983-01-06
NL166622C (en) 1981-09-15
FR2257305B1 (en) 1982-03-19
ES433759A1 (en) 1977-02-16
NO143128B (en) 1980-09-15
BE824372A (en) 1975-07-14
AU7730575A (en) 1976-07-15
CS191254B2 (en) 1979-06-29
MY8100204A (en) 1981-12-31
YU5875A (en) 1984-04-30
DE2500785A1 (en) 1975-07-31
HU173920B (en) 1979-09-28
GB1498261A (en) 1978-01-18
PH14458A (en) 1981-07-29
FI750014A (en) 1975-07-15
DE2500785B2 (en) 1980-01-03
SU616997A3 (en) 1978-07-25
FI54053C (en) 1978-10-10
NL166622B (en) 1981-04-15
SE7500130L (en) 1975-07-15
DD116239A5 (en) 1975-11-12
JPS56127319A (en) 1981-10-06
PL93689B1 (en) 1977-06-30
NO750031L (en) 1975-08-11
IL46426A (en) 1978-01-31
DE2500785C3 (en) 1980-09-11
JPS6035326B2 (en) 1985-08-14
CH589453A5 (en) 1977-07-15
AT345449B (en) 1978-09-11
AU500250B2 (en) 1979-05-17
IL46426A0 (en) 1975-04-25
NO143128C (en) 1980-12-29
ZA75259B (en) 1976-08-25
IE40794B1 (en) 1979-08-15
IE40794L (en) 1975-07-14
DK1475A (en) 1975-09-01
FI54053B (en) 1978-06-30
CA1049406A (en) 1979-02-27
NL7500301A (en) 1975-07-16
ATA21475A (en) 1978-01-15
JPS50100224A (en) 1975-08-08

Similar Documents

Publication Publication Date Title
FR2283703B3 (en)
DK140003C (en)
FR2261450B3 (en)
JPS50128504A (en)
JPS50152931A (en)
FR2280270B1 (en)
JPS50136913A (en)
JPS5132106A (en)
JPS50144924U (en)
JPS50156336U (en)
JPS5138811U (en)
JPS50155003U (en)
JPS50122343A (en)
JPS50151106U (en)
JPS50108755U (en)
CH571754A5 (en)
CH578457A5 (en)
CH572126B5 (en)
BG22604A1 (en)
CH571090A5 (en)
CH571085A5 (en)
CH574144A5 (en)
CH569861A5 (en)
CH569102A5 (en)
BG26362A3 (en)

Legal Events

Date Code Title Description
PBP Patent lapsed